Management Team

Henri Harland, CEO & President

  Mr. Henri Harland, visionary and founder of Neptune Technologies & Bioressources Inc., has served as a director and the President and Chief Executive Officer of the Company since its incorporation on October 9th, 1998. He has been involved in the krill research project since 1991 and was a pioneer in forseeing nutrigenomics. Mr. Harland’s vision, passion, dedication, creativity and leadership, over an extended period of time, resulted in building Neptune and creating the remarkable product that Neptune Krill Oil is today. Since 1998, he has held the position of President and Chief Executive Officer of Groupe Conseil Harland inc., a financial engineering group. From May 1992 to September 1997, Mr. Harland was a director and acted as Vice-president of Corporate Development and Chief Financial Officer of SignalGene inc. (formerly Société Algène Biotechnologies Inc.), a publicly traded biotechnology corporation.

Tina Sampalis M.D., Ph.D., Chief Scientific Officer

  Dr. Tina Sampalis is an Oncology Surgeon, trained in Physiology at McGill University, Medicine at the University of Patras (Greece), Dermatology at Göttingen University (Germany) and Marselisborg University (Denmark), Pediatric, General and Oncology Surgery at the University of Athens (Greece), graduate training (PhD) in Surgical Research at the University of Athens and a second PhD in Epidemiology and Experimental Surgery at McGill University. She has received several international scholarships and awards for her work on the clinical implementation of retinols skin and breast cancer including the Helen Hutchison Award for geriatric medicine. Her work on Scintimammography resulted in her appointment at the International Educational Speakers Bureau, the Canadian and U.S. Faculty of Medical Speakers for Breast Imaging. As an international scholar she leads the development and implementation of innovative micro-invasive and stereotactic robotic surgical techniques for breast cancer, for which a USA and Canadian patent application has been filed. She is a member of the American Association of Naturopathic Medicine. Dr. Sampalis is published multiple times in peer reviewed publications and has presented at international conferences. Since May 2000 she has held the position of vice-president of Research & Business Development Since June 2007 she has held the position of Chief Scientific Officer of Neptune Technologies & Bioressources Inc. and has been devoted to the research and development of Neptune Krill Oil.

André Godin, Vice-President, Administration & Finance

  Mr. André Godin, C.A. has a Bachelor in Administration and is has been a Member of the Canadian Institute of Chartered Accountants since 1988. He has more than 10 years experience in the Biotech/Pharma industry as former President of a Dietary Supplement Company and as a Corporate Controller for a pharmaceutical company in OTC products. Mr. Godin has been Vice-President, Administration and Finance for Neptune Technologies & Bioressources Inc. since 2003.

Thierry Houillon, Vice-President, Nutraceutical

  Mr. Thierry Houillon has been the President and Chief Executive Officer of Danone Eaux Canada from 2003 to 2006 and of Danone Yoghourt Tunisia from 2001 to 2003 and of Danone Yoghourt Canada from 1994 to 2001. Since February 2007 he has held the position of vice-president Business Development Functional Foods. Mr. Houillon has been Vice-President, Nutraceutical for Neptune Technologies & Bioressources Inc. since June 2007. He is also Director of the board for the company.

Dr. Toni Rinow, Corporate Development & Investor Relations

  Dr. Toni Rinow has gained solid experience in the life science sector, particularly in the areas of corporate development, investor relations and financing. She was involved in transitioning two biotechnology companies, ConjuChem and MethylGene, to an initial public offering at the Toronto Stock Exchange raising over $40 million in total. In addition, she ran the life science investment portfolio of the Fonds de Solidarité with $400 million under management. Dr. Rinow was involved in the negotiation of international corporate alliances with pharmaceutical companies worth over $100 million. She holds a doctorate in physical chemistry from the University of Montreal and completed an engineering degree in chemistry from École Nationale Supérieure d'Ingénieur in Strasbourg, France. Dr. Rinow completed her training with an MBA from McGill University in Montreal. Since September 2007, Dr. Rino is responsible for the Corporate Development & Investor Relations activities at Neptune Technologies & Bioressources Inc.